News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Novartis to buy Seattle biotech firm Chinook Therapeutics in $3.2B deal
Novartis announced that it will be purchasing Chinook Therapeutics, a Seattle-based biotech company, for $3.2 billion. Founded in 2019, Chinook Therapeutics focuses on developing treatments
Variant Bio turns focus from identifying genomic variants to drug discovery
Seattle-based biotech company Variant Bio will be creating new therapeutic programs to enhance its current research on genomic variants. The addition of Dr. David Moller
Seagen shareholders approve $43B acquisition by Pfizer
Seagen, a Bothell biotech company, is set to be acquired by Pfizer Pharmaceuticals following a shareholder vote on May 30. The $43 billion purchase is
A Home to Amazon, Starbucks, and Biotech Too
Biotech news organization Big4Bio invited journalist Luke Timmerman on its podcast to discuss Seattle’s growing biotech industry. Big4Bio amasses news on the four main biotech
Mozart Therapeutics adds $25M to earlier Series A round
Seattle-based biotech Mozart Therapeutics, which generates treatments for inflammatory and autoimmune diseases, has raised $25 million in funding. This investment follows an initial $55 million
Achieve Life Sciences raises $16.5M in pursuit of anti-smoking drug
Achieve Life Sciences (Achieve), a Bothell-based biotech company, has raised nearly $16.5 million. According to the company, the funding was secured through a registered direct
Cadence Neuroscience raises $26M to develop neural implants
Redmond-based startup Cadence Neuroscience raised $26 million in a Series B funding round that will be used toward finishing clinical studies and working on receiving
Cancer-focused biotech startup OncoResponse raises $27M
Seattle-based biotech startup OncoResponse raised $14 million in venture funding and a $13 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT).
Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle
Seattle-based biotech Outpace Bio opened a new 23,000-square-foot facility as the company has new research and development efforts underway and has grown to 53 employees.
Cancer-fighting biotech startup Indapta lands $30M with assist from FDA
Seattle-area company Indapta Therapeutics has triggered round two of the $60 million Series A round raised in January 2022. The company received Food and Drug
A-Alpha Bio lands $2.4M from DOD for antibody discovery project
Seattle-based biotech A-Alpha Bio has received $2.4 million from the Department of Defense (DOD) in a joint project with Lawrence Livermore National Laboratory (LLNL). A-Alpha
Seattle startup raises $2M to make healthcare pricing data more transparent
Seattle-based startup Cascade Health raised $2 million in a pre-seed funding round to help boost its AI-powered software. The company’s software aims to increase healthcare